Cargando…
Efficacy of a Virus-Like Nanoparticle As Treatment for a Chronic Viral Infection Is Hindered by IRAK1 Regulation and Antibody Interference
Although vaccination has been an effective way of preventing infections ever since the eighteenth century, the generation of therapeutic vaccines and immunotherapies is still a work in progress. A number of challenges impede the development of these therapeutic approaches such as safety issues relat...
Autores principales: | Chartrand, Karine, Lebel, Marie-Ève, Tarrab, Esther, Savard, Pierre, Leclerc, Denis, Lamarre, Alain |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758502/ https://www.ncbi.nlm.nih.gov/pubmed/29354118 http://dx.doi.org/10.3389/fimmu.2017.01885 |
Ejemplares similares
-
Plant Viruses as Nanoparticle-Based Vaccines and Adjuvants
por: Lebel, Marie-Ève, et al.
Publicado: (2015) -
Type I Interferon Impairs Specific Antibody Responses Early during Establishment of LCMV Infection
por: Daugan, Matthieu, et al.
Publicado: (2016) -
Expression of Viral Antigen by the Liver Leads to Chronic Infection Through the Generation of Regulatory T Cells
por: Lapierre, Pascal, et al.
Publicado: (2015) -
Regulation of innate immune signaling by IRAK proteins
por: Pereira, Milton, et al.
Publicado: (2023) -
Influence of PapMV nanoparticles on the kinetics of the antibody response to flu vaccine
por: Rioux, Gervais, et al.
Publicado: (2016)